ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103043 | 3-year financial timeline | COVID resilience: 67/100
🛡️ Public data only — no PHI permitted on this instance.
$30M
Latest Revenue (FY2022)
+9.6%
Revenue CAGR (3yr)
14.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $25M | $29M | $30M | +4.3% | +9.6% |
| Operating Expenses | $22M | $26M | $26M | -0.3% | +8.1% |
| Operating Margin | 11.7% | 10.1% | 14.1% | +38.9% | +9.9% |
| Net Income | $3M | $3M | $4M | +44.9% | +20.5% |
| Licensed Beds | 80 | 80 | 80 | +0.0% | +0.0% |
| Total Patient Days | 18,279 | 19,712 | 19,868 | +0.8% | +4.3% |
| Medicare Day % | 64% | 61% | 59% | -3.9% | -3.9% |
| Medicaid Day % | 0% | 0% | 0% | -33.1% | -43.0% |
COVID Impact & Recovery
Resilience Score: 67/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +20.2% ($25M → $30M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.6%
This Hospital
+7.6%
State Avg
Latest Margin
14.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | 15.3% |
| FY2024 (proj) | $35M | 16.5% |
| FY2025 (proj) | $38M | 17.7% |